A B S T R A C T To investigate the role of glucagon and insulin receptor binding in the glucagon hypersensitivity and insulin resistance which characterize the glucose intolerance of uremia, liver plasma membranes were prepared from control rats (blood urea nitrogen [BUN] 15±1 mg/100 ml, creatinine 0.7±0.2 mg/100 ml), and from 70% nephrectomized rats (BUN 30±2 mg/100 ml, creatinine 2.2±0.2 mg/100 ml), and from 90% nephrectomized rats (BUN 46±3 mg/100 ml, creatinine 4.20+0.7 mg/100 ml), 4 wk after surgery. As compared to controls, the 90% nephrectomized rats had significantly higher levels of plasma glucose (95 ±4 vs. 125±11 mg/100 ml), plasma insulin (28±9 vs. 52±11 uU/ml), and plasma glucagon (28±5 vs. 215 ±18 pg/ml). Similar, but less marked, elevations were observed in the 70% nephrectomized animals.
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In liver plasma membranes from nephrectomized rats, specific binding of 1251-glucagon was increased by 80-120%. Furthermore, glucagon ( (1) . The reduction in glucose tolerance is characterized by increased insulin levels (2) and diminished responses to endogenous (3) and exogenous insulin (4) , suggesting insulin resistance. In addition to alterations in insulin, uremia is characterized by hyperglucagonemia (5, 6) and an increased sensitivity to glucagon-induced hyperglycemia (6) . This hypersensitivity to glucagon is reversible after dialysis (6) . The pathogenesis and cellular mechanism of glucagon hypersensitivity and insulin resistance in uremia have not been established. Changes in insulin binding to tissue receptors have recently been implicated in the insulin resistance of obesity (7) and in diabetic patients with acanthosis nigricans (8) . Only limited data are available concerning altered glucagon binding in disorders of carbohydrate metabolism (9, 10) . The present study was consequently undertaken to determine whether increased glucagon sensitivity and insulin resistance in uremia might be mediated by alterations in the binding of these peptide hormones to their specific liver plasma membrane receptors. In this investigation, insulin and glucagon binding to hepatic plasma membranes has been studied groups of rats were studied: control rats with intact kidneys, and two groups of experimental animals with renal insufficiency. The renal insufficiency was produced by surgical ablation of approximately 70% (group I) and 90% (group II) of the renal mass using the technique described by Kaufman et al. (11) . All animals were placed in individual cages and allowed 20 g of standard Purina chow per day (Ralston Purina Co., St. Louis, Mo.). All food was consumed daily, indicating that dietary intake was comparable in all three groups. The body weights (mean+SEM) of the three groups of experimental animals at the beginning and at the end of the 4-wk study period were as follows: control rats, 202+12 and 322±14 g, respectively; 70% nephrectomy group, 196 ± 10 and 306±19 g, respectively; and 90% nephrectomy group, 206±15 and 291±12 g, respectively. Animals were fasted 8-10 h before sacrifice. They were sacrificed 28 days after surgery, since previous work has shown that the compensatory response to renal ablation is complete by 14-21 days after surgery (12) . Livers were quickly removed from 10 to 15 rats from each group (control, 70%o nephrectomy, and 90% nephrectomy), and blood was obtained by aortic puncture for measurement of blood urea nitrogen (BUN), creatinine, glucose, insulin, and glucagon.
Preparation of liver plasma membranes. After removal, livers were quickly minced in 0.25 M ice-cold sucrose and homogenized in 0.001 M NaHCO3 solution in a Dounce homogenizer at 4°C (Kontes Co., Vineland, N. J.). Partially purified plasma membranes were prepared by the method of Neville (13) as modified by Pohl et al. (14) . The preparation sequence was rigidly followed for membranes of all three groups of rats, and specific activity of the membrane marker enzyme, 5'-nucleotidase was measured by the method of Avruch and Wallach (15) . Membrane protein was estimated by the method of Lowry et al. (16) . Membrane preparations were stored in small aliquots at -70°C for 3 mo without any significant decrease in adenylate cyclase activity or hormone binding.
lodination of insulin and glucagon. 125I-Insulin was prepared by the chloramine-T method at specific activities of 100-150 ,uCi/,ug according to the method of Freychet et al. (17) . This method has been shown to yield a biologically active monoidoinsulin preparation.
Glucagon was iodinated by a modification (18) of the Hunter and Greenwood method (19) . 10 ul of a 10-4 M glucagon solution (1 nmol) in 0.5 M NaPO4 buffer, pH 7.4 was added to 1 nmol of carrier-free 125I-Na (in 0.1 N NaOH) in a 13 x 100-mm glass tube. A freshly prepared solution of chloramine-T (10 ,ul of 3.5 mg/ml in 0.5 M phosphate buffer) was added, and the reagents were mixed rapidly. 50 ,ul of sodium metabisulphite solution (2 mg/ml) was added immediately (within 5 s) and mixed rapidly. This was immediately followed by addition of 150 ,ul of 10 mM NaPO4 buffer, pH 7.4 with 1% bovine serum albumin (BSA).' The reaction mixture was applied to a 0.4-ml column of cellulose in a Pasteur pipette which had been equilibrated with phosphate buffer (10 mM pH 7.4%) and was washed with 1% BSA solution. The column was eluted successively with 10 mM phosphate buffer, containing 1% BSA, H20, and 50% ethanol in 10 mM Tris HCI, pH 7.6 (17) . The specific activity of 1251-glucagon was 150-200 ACiY/Ag. Trichloroacetic acid precipitability of both iodinated hormones was -95%. Iodinated hormones were stored at -200C and used within 2 wk.
Glucagon binding assay. The binding of '25I-glucagon to hepatic plasma membranes were carried out according to ' Abbreviation used in this paper: BSA, bovine serum albumin. the method of Rodbell et al. (20) . Liver membranes (30-50 ,g protein) were incubated for 15 min at 30°C in a medium containing 20 mM Tris-HCl, 1 mM EDTA, 2% BSA pH 7.6, 2 nM 1251-glucagon and varying concentrations of unlabeled glucagon. The incubation volume was 250 ,l. At the end of the incubation period, 50-,l aliquots of the incubation mixture were layered over 250 ,ul of a solution containing 20 mM Tris-HCl, pH 7.6, with 2% BSA in plastic microfuge tubes. The tubes were centrifuged immediately in a Beckman microfuge model B (Beckman Instruments, Inc., Fullerton, Calif.) at 4°C for 5 min. The supernatant fluid was aspirated, and the pellet was gently washed with 300 ,ul of cold 10%o sucrose. After aspirating the fluid, the tip of the centrifuge tube was cut just above the pellet, and the pellet was counted in a gamma counter. The specific binding of l25I-glucagon was calculated by subtracting nonspecific binding l25I-glucagon bound in the presence of 1,000 ng/ml glucagon from the total 1251-glucagon binding (in the absence of unlabeled glucagon).
Measurements of adenylate cyclase activity. Adenylate cyclase activity in liver membranes was measured according to the procedure described by Steiner et al. (21) . The incubation medium contained in 100 Al, 20 mM Tris-HCl, pH 7.6, 5 mM MgCl2, 1 mM EDTA, 10 mM theophylline, 0.15% BSA, 4 mM ATP, creatine kinase (1 mg/ml), 25 mM phosphocreatine, and 50-60 ,g of membrane protein.
Creatine kinase and phosphocreatine solutions were prepared fresh for each experiment. Stimulation of adenylate cyclase activity was measured by the addition 2 ,LM glucagon and 15 mM NaF. Incubation was carried out for 10 min at 30°C, and the reaction was stopped by boiling for 3 min. After centrifugation at 3,000 rpm for 15 min at 5°C, aliquots of supernate were assayed for 3',5'-cyclic AMP by radioimmunoassay (21) . Specificity of the assay was confirmed by demonstrating that cyclic AMP could no longer be measured after treatment of membranes with purified bovine phosphodiesterase. Recovery of added cyclic AMP in the assay system was at least 90%.
Insulin binding assay. 1251-Insulin binding studies were conducted at 30°C in Krebs-Ringer phosphate buffer (140 mM NaCl, 1.7 mM KC1, 0.4 mM Mg S04, 1.5 mM KH2 P04) pH 7.5, containing 1% BSA in a final volume of 0.5 ml/incubation tube. The latter contained 0.2 ng/ml of l25I-insulin, 80-120 ,ug of membrane protein, and varying concentrations of unlabeled insulin. At the end of the 60-min incubation period, 200-.L aliquots were layered over 100 ,ul of Krebs-Ringer phosphate buffer in microfuge tubes, and l25I-insulin bound to membranes was separated by the method used for glucagon binding described earlier.
Data analysis of insulin binding. The specific binding of 1251-insulin was calculated by subtracting nonspecific binding (l25I-insulin bound in the presence of 1,000 ng/ml of unlabeled insulin) from the total l25I-insulin binding ('25I-insulin bound in absence of unlabeled insulin). Insulin binding data were analyzed by two methods, Scatchard analysis (22) and the "average affinity profile" (23) . In Scatchard analysis (22) , bound/free l25I-insulin is plotted as a function of bound (B) hormone, and the total binding capacity or total receptor concentration (Ro) is derived from the point where the linear extraporation of the curve intersects the horizontal axis. Because the insulin receptor sites are not independent of one another (24) , estimation of affinities of the binding sites for curvilinear Scatchard plots may not be valid (25) . Therefore, we have also analyzed insulin binding data employing the "average affinity profile" method described by De Meyts and Roth (23) . The average affinity profile expresses the relationship between average affinity for insulin (K) and receptor occupancy (Y), and the validity of this analysis does not depend upon assigning a particular model to the molecular mechanisms involved in the cooperativity behavior of insulin-binding sites (23 Blood and plasma measuremeitts. Plasma immunoreactive insulin and immunoreactive glucagon (using Unger antibody 30K) were detennined as described previously (26) . Glucose was measured by the glucose oxidase technique (27) . BUN and creatinine were determined by standard laboratory technics.
RESULTS
As shown in Table I , the BUN was double the control value in the 70% nephrectomized rats and three times the control level in the 90% nephrectomy group.
Creatinine levels were similarly elevated in nephrectomized animals. Plasma glucose concentrations were 25-30 mg/100 ml higher in both groups of uremic rats. Plasma insulin was 50 and 95% higher in 70 and 90% nephrectomized rats respectively, as compared to normals. In addition, plasma glucagon levels were increased fourfold in the 70%o nephrectomized group and rose sixfold in the 90% nephrectomized rats.
Evaluation of membrane purification procedure. Table II summarizes the protein yield and 5'-nucleotidase activity in whole liver homogenates and partially purified membranes from control and 90%o nephrectomized rats. It is evident that the yield of protein and the activity of 5'-nucleotidase were virtually identical in both groups of rats. These findings provide evidence that nephrectomy and azotemia had no systematic effect on the membrane isolation procedure to account for the differences in honnone binding and enzyme activity described below.
Effect of nephrectomy on glucagon binding and adenylate cyclase activity. Specific binding of 125I- glucagon was studied in the control rats and in the two groups of nephrectomized rats. Glucagon binding was found to be linear over a range of protein concentrations of0.025-1.2 mg/ml. The results shown in Table  III are calculated for 0.2 mg membrane protein/ml.
Specific binding of 125I-glucagon was 80 and 120%o higher in the 70 and 90% nephrectomized rats respectively, than in control rats (P < 0.001, Table III ). In contrast to specific binding of l25I-glucagon, the nonspecific binding of labeled glucagon was identical in control (1.3%) and in 70 and 90%o nephrectomized rats (1.4 and 1.5%, Table III ).
The finding of significantly increased specific binding of glucagon in uremic rats led us to investi- Table IV . In both groups of uremic rats basal adenylate cyclase activity was 50% higher than in control rats (P < 0.01). Furthermore, glucagon-stimulated adenylate cyclase activity in uremic rats was 90-100% higher than in control rats (P < 0.001, Table IV (Table IV ).
In Fig. 1 , the effects of varying concentrations of glucagon on the binding of '251-glucagon and on glucagon-stimulated adenylate cyclase activity are compared. In uremic rats 125I-glucagon binding was higher than in control rats at each glucagon concentration. Based on the specific activity of the labeled glucagon the amount of glucagon bound at saturation was calculated to be 3 Degradation of glucagon by liver membranes. To examine the possibility that decreased glucagon degradation by liver membranes from uremic rats may account for increased glucagon binding by these mem- branes, the glucagon inactivation process was studied. Table V shows the degradation of 1251-glucagon by liver membranes from control and nephrectomized rats. Glucagon degradation activity was found to be linear over a membrane protein concentration of 0.05-2.5 mg/ml of incubation medium. Liver membranes from control and uremic rats inactivated glucagon to the same extent (40-45%) at a membrane protein concentration of 0.2 mg/ml.
Effect of nephrectomy on insulin binding in liver membranes. To examine the possibility that insulin resistance observed in uremic rats may be related to alterations in insulin binding, we studied the binding of monoiodoinsulin to liver plasma membranes from 15 control rats and 15 uremic rats (90% nephrectomy). As shown in Table VI the specific binding of 1251_ insulin in uremic rats was 45% lower than in normal control rats (P < 0.001). The nonspecific binding was identical in control (2.0%) and in 90% nephrectomized rats (2.1%) ( Table VI) . The displacement curves of 1251-insulin by addition of increasing concentrations of unlabeled insulin in control and 90% nephrectomized rats are shown in Fig. 2 . As shown, the binding of insulin was consistently reduced by 40-50% in the nephrectomized rats at all concentrations of insulin between 0.1 and 100 ng/ml. Scatchard analysis of the insulin binding data revealed curvilinear plots for both control and uremic rats which were parallel (Fig. 3) . The total calculated insulin binding capacity in the nephrectomized rats (0.95 pmol/mg protein) was 45% lower than in control rats (1.75 pmol/mg protein). The relationship between changing receptor affinity for insulin and occupancy of receptor sites by the hormone is expressed by the "average affinity profile" (23) shown in Fig. 4 . The shape of the average affinity profile in both control and uremic rats is consistent with a system displaying the phenomenon of negative cooperativity (23 Degradation of insulin by liver membranes. Table  V shows the data on insulin degradation by liver membranes from control and uremic rats. Liver membranes from both control and 90% nephrectomized rats inactivated insulin to the same extent as measured by TCA precipitation and specific binding to liver membranes. These data indicate that decreased insulin binding in nephrectomized rats does not appear to be related to alterations in the insulin inactivation process in these membranes.
DISCUSSION
Insulin and glucagon play a central role in alterations of fuel homeostasis in many diseases. Uremia is char- acterized by hyperinsulinemia, insulin resistance, and hyperglucagonemia. In addition, recent studies from our laboratory indicate that there is increased sensitivity to glucagon-induced hyperglycemia in uremia (6) . In the present study we examined the binding of 1251-glucagon and '251-insulin to liver plasma membranes from 70 and 90% nephrectomized rats in order to explore the possibility that changes in glucagon and insulin receptors may account for glucagon hypersensitivity and insulin resistance in uremia.
The nephrectomized uremic rat model employed in the present study exhibited a moderate elevation of BUN and creatinine, hyperglycemia, hyperinsulinemia, and hyperglucagonemia (Table I) , which are all characteristics of carbohydrate intolerance in uremic humans (1, 6) . While heterogeneity of plasma glucagon has been noted in uremia, an absolute increment in true pancreatic glucagon (3,500 mol wt) has been observed in uremic humans as well as experimental animals (28) . Thus, the nephrectomized uremic rat appears to be a good model to investigate glucose intolerance in uremia. The studies of 1251-glucagon binding to hepatic membranes indicate that specific binding of 1251-glucagon was approximately twofold higher in nephrectomized rats than in control rats (Table III) . Glucagon binding was somewhat higher in the 90% as compared to the 70% nephrectomized group. The findings with regard to recovery of plasma membrane and 5'-nucleotidase activity (Table II) indicate that the increment in glucagon binding cannot be explained by a systematic effect of uremia on the membrane purification procedure. Analysis of glucagon-binding data is complex and controversial (29, 30) . Nevertheless, our data demonstrating a consistent increase in glucagon binding in nephrectomized rats at all concentrations of glucagon ( Fig. 1 ) may be interpreted to indicate that the increase in glucagon binding in nephrectomized rats is mainly a result of an increase in the number of binding sites rather than a significant change in binding affinity.
The interaction between glucagon and its target organs has been shown to involve three closely related processes: glucagon binding, adenylate cyclase activation, and glucagon degradation (29) . The finding of increased glucagon binding in livers from nephrectomized rats led us to investigate adenylate cyclase activity and glucagon degradation in liver membranes from the same groups of rats. We found that basal adenylate cyclase activity in uremic rats was 50% higher in uremic rats than in control rats. As noted above, this observed difference in adenylate cyclase activity is unlikely to be a result of differences in the membrane purification procedure (Table  II) . Of even greater interest was the finding that glucagon-stimulated adenylate cyclase activity in uremic rats was twofold higher than in control rats. In contrast to glucagon-stimulated adenylate cyclase activity, the stimulatory effect of sodium fluoride was not significantly increased in nephrectomized rats. These findings thus indicate that the augmented stimulation of adenylate cyclase by glucagon in uremic rats is not a consequence of a nonspecific increase in responsiveness of this system to all stimuli. Furthermore, the data indicate that augmented receptor binding of glucagon in uremia is accompanied by enhanced stimulation of postreceptor events. The importance of altered glucagon binding in hepatic cell metabolism in uremia is further underscored by the comparability of changes in hormone binding and adenylate cyclase activity over varying concentrations of glucagon (Fig.  1 ). However, it should be emphasized that the intracellular action of glucagon, as in the case of catecholamines (31) may not be dependent on changes in adenylate cyclase activity.
To examine the possibility that increased glucagon binding and adenylate cyclase activity may be a consequence of a significant decrease in glucagon degradation activity in liver membranes from uremic rats, we studied the glucagon inactivation process in these membranes. Our data indicate that glucagon degrading activity in uremic rats was similar to that of control rats (Table V) (Fig. 2) . Furthermore, our data on insulin degradation by liver membranes (Table V) indicate that decreased insulin binding in these rats is not a result of changes in the insulin degradation process, since membranes from uremic and control rats inactivated insulin to the same extent. Analysis of the insulin binding data by Scatchard plot indicates that decreased specific binding of 1251-insulin in uremic rats is not a result of a decrease in the affinity of insulin receptors (Fig. 3) . Since estimation of affinities of binding sites by curvilinear Scatchard plots may not be valid (25) , the insulin binding data were also analyzed by the "average affinity profile" method of De Meyts and Roth (23) . By that procedure, control and nephrectomized rats revealed identical affinity profile plots (Fig. 4) . Thus, the analysis of insulin-binding data indicates that decreased insulin binding in uremic rats is mainly a result of a decrease in binding capacity rather than a significant change in binding affinity.
Regarding the pathogenesis of decreased insulin binding in uremia, it is of note that an inverse relationship between ambient insulin levels and insulin receptor concentration has been demonstrated in conditions such as obesity (7) and in experiments with cultured human lymphocytes (32) . It is thtus conceivable that decreased insulin binding observed in our uremic rat model is a consequence of hyperinsulinemia in these animals. It is also possible that some metabolic product in uremic plasma may affect insulin (and glucagon) binding. Irrespective of the mechanism involved, the fact that insulin and glucagon binding are oppositely affected excludes a systematic, nonspecific action of the uremic state on polypeptide hormone binding to liver receptors.
With respect to the significance of the decrease in instulin binding, a positive correlation between insulin binding and in vivo action of insulin has been reported in obesity (35) . On the other hand, other studies have shown that changes in insulin binding and action may be divergent in starvation (36) and in diabetes (37) . The current findings provide evidence that diminished insulin binding may be a contributory factor in the insulin resistance and glucose intolerance of uremia.
